ESC Premium Access

Antiplatelet therapy and adverse outcomes in high cardiovascular risk elderly patients: a sex and gender focused analysis from REPOSI study

Congress Presentation

About the speaker

Doctor Marco Proietti

IRCCS Clinical Scientific Institute Maugeri, Milan (Italy)
6 presentations
0 follower

6 more presentations in this session

Stroke rate after twelve versus 30 month dual antiplatelet therapy in percutaneous coronary intervention patients using korean national health insurance service (nhis)

Speaker: Ms S. Kang (Busan, KR)


Temporal trends in the use of antiplatelet therapy in patients with acute coronary syndromes

Speaker: Doctor M. Esteve Pastor (Murcia, ES)


The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy.

Speaker: Mr W. Liu (Beijing, CN)


Efficacy and safety of perioperative aspirin therapy in non-cardiac surgery: a systematic review and comprehensive meta-analysis of randomized controlled trials

Speaker: Mr G. Wolff (Duesseldorf, DE)


Anti-platelet effect of intravenous P2Y12 receptor inhibitor cangrelor is not influenced by reticulated platelets

Speaker: Doctor C. Stratz (Bad Krozingen, DE)


Access the full session

Remaining in the spotlight: antiplatelet agents

Speakers: Doctor M. Proietti, Ms S. Kang, Doctor M. Esteve Pastor, Mr W. Liu, Mr G. Wolff...

About the event



26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk